BluDog Receives Initial Inventory -- Retail Value of $1.4 Million

SARASOTA, Fla., Oct. 03, 2017 (GLOBE NEWSWIRE) -- BluDog Products LLC, a subsidiary of International Consolidated Companies, Inc. (OTC:INCC), has received initial inventory of 10,0000 Zenium 30 packs that have a retail value of $1.4 million.

A photo accompanying this announcement is available at

BluDog is marketing its CBD products both direct to consumer and to distributors through specific distribution channels through its online store:

BluDog also intends to distribute its product through doctor’s offices (M.D., O.D., Chiropractors, Alternative Medicine and Wellness Centers).

Additionally, BluDog is pursuing the Medical Day Spa and Resort Spa markets.   BluDog is in final negotiations with Esthetic Treatment Centers, based in Naples, FL,, to distribute BluDog’s products.  Esthetic Treatment Centers is embarking on a 200 plus store nationwide expansion.

“I believe CBD will be the next major breakthrough in the cosmetic and wellness industry.  We are excited to partner with BluDog as it’s products are the highest quality and the smartest most effect delivery systems,” said Mindy DiPietro, COO, Esthetic Treatment Centers.

BluDog Products is strategically introducing a water-soluble CBD oil super food and wellness drinks (with an extended release formulation) that are easily absorbed. Using a licensed, patented CBD delivery system BluDog’s CBD products are an alternative over-the-counter therapeutic option to help relieve post-sports inflammation as well as promote relaxation and well-being. BluDog’s CBD products interact naturally with the body’s anti-inflammatory system without any known side effects.

International Consolidated Companies (INCC) was founded in 2002. INCC is focused on acquiring and growing businesses that offer innovation, quality, and cost-efficient Cannabis technologies.

Forward-looking disclaimer
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material may contain statements about expected future events and/or financial results that are forward-looking in nature and subject to risk and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements to be materially different from the statements made herein. 

More Information: Antonio F. Uccello, INCC; (720-460-0734) (,, @BluDogProducts
SOURCE: International Consolidated Companies, Inc.

Zenium shipment